Selecting the right disease or condition is critical when entrepreneurs are establishing their business models. Identifying the right one can often make or break a company and its future opportunities.
In this webinar, Erich Scheller, PhD, Director of RA Capital’s TechAtlas, discusses how RA Capital thinks about choosing indications and pursuing investments as a leading venture investor in today’s markets.